Comments
Loading...

ArriVent BioPharma Earnings Estimates

AVBPNASDAQ
Logo brought to you by Benzinga Data
$20.63
0.160.78%
At close: -
$20.47
-0.16-0.78%
After Hours: 9:00 AM EDT

ArriVent BioPharma Earnings Estimates, EPS & Revenue | NASDAQ:AVBP | Benzinga

ArriVent BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 12
EPS
$-1.900
Quarterly Revenue
$0.00
Annual Revenue
(as of Mar 31)

Analyze the earnings history of ArriVent BioPharma using advanced sorting and filters.

Get Alert
AVBPArriVent BioPharma-$0.65$0.0008/13/2025Get Alert
AVBPArriVent BioPharma-$0.70-$0.69-$1.90-175.36%$0.00$0.0005/12/2025Get Alert
AVBPArriVent BioPharma-$1.10-$0.6144.55%$0.0003/03/2025Get Alert
AVBPArriVent BioPharma-$5.52-$0.82-$0.6125.61%$0.00$0.0011/13/2024Get Alert
AVBPArriVent BioPharma-$10.79-$0.54-$0.65-20.37%$0.00$0.0008/14/2024Get Alert
AVBPArriVent BioPharma-$9.45-$1.05-$0.7033.33%$0.00$0.0005/08/2024Get Alert

ArriVent BioPharma (AVBP) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q12025-05-12$-1.90$-0.69-175.4 %
Q42025-03-03$-0.61$-1.1044.5 %
Q32024-11-13$-0.61$-0.8225.6 %
Q22024-08-14$-0.65$-0.54-20.4 %

ArriVent BioPharma (AVBP) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?

A

ArriVent BioPharma (AVBP) is scheduled to report earnings on August 13, 2025. The last reported earnings were for reported on May 12, 2025 for Q1.

Q

What were the latest earnings per share (EPS) for ArriVent BioPharma (NASDAQ:AVBP)?

A

The Actual EPS was $-1.90, which missed the estimate of $-0.69.

Q

What were ArriVent BioPharma’s (NASDAQ:AVBP) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch